New colleague at SenzaGen

Welcome to SenzaGen Anna Chérouvrier Hansson!

Anna has started her position as Chief Commercial Officer with us here at SenzaGen this week. Anna comes from Camurus, a pharmaceutical company developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions. At Camurus, Anna was Director of Marketing and responsible for the Medical Device Business Unit. She has previously worked as Head of Business Development Life Science at Invest in Skåne, Partner at Zitha Consulting and in a number of senior positions in European pharmaceutical and chemical companies. Anna was born in France, studied and worked in Germany and Luxembourg before moving to Sweden in 2000 to study a Master in Business Administration and Business Law and decided to stay. Anna strengthens SenzaGen’s management for the commercialization of the GARD tests and prior to the company’s planned listing on Nasdaq First North.

We are very happy to have you in our team, Anna!

You might also like
Senzagen price and winnerSenzaGen once again makes it to the 33-list
blue senzagen logoSenzaGen starts blogging for Swedish leading financial newspaper Dagens Industri.
blue senzagen logoSenzaGen receives financial support
senzagen member of the boardIan Kimber joins the board of SenzaGen AB
Lund universitySenzaGen AB attracts financial support from LU Innovation System AB.
blue senzagen logoSenzaGen initiates cooperation with partners in Europe and the US
Almi Invest awards SenzaGen the prestigeous Annual Keywhole investment prize. “Årets titthålsinvestering”
SenzaGen one of the five most praised companies in Swedish business media